Inhalant use, unspecified, uncomplicated
ICD-10 F18.90 is a billable code used to indicate a diagnosis of inhalant use, unspecified, uncomplicated.
F18.90 refers to the use of inhalants, which are substances that produce chemical vapors that can be inhaled to induce psychoactive effects. This code is used when the inhalant use is unspecified and uncomplicated, meaning there are no associated complications such as withdrawal or intoxication symptoms that require further specification. Inhalant use can lead to a range of health issues, including neurological damage, respiratory problems, and potential for addiction. The clinical presentation may vary widely, from occasional use without significant impairment to more frequent use that can lead to dependency. Treatment for inhalant use disorder typically involves behavioral therapies, counseling, and support groups, as there are no specific pharmacological treatments approved for inhalant addiction. It is crucial for healthcare providers to document the extent of use, any associated health issues, and the patient's treatment plan to ensure accurate coding and appropriate care.
Detailed history of substance use, treatment plans, and follow-up assessments.
Patients presenting with inhalant use without acute intoxication or withdrawal symptoms.
Consideration of co-occurring mental health disorders and comprehensive treatment approaches.
Psychiatric evaluations, treatment progress notes, and any co-morbid conditions.
Patients with inhalant use presenting with anxiety or mood disorders.
Assessment of the psychological impact of inhalant use and integration of mental health treatment.
Used when counseling a patient about inhalant cessation.
Document the counseling session details and patient response.
Addiction specialists may need to provide additional resources for inhalant cessation.
F18.90 indicates unspecified inhalant use that is uncomplicated, meaning there are no associated withdrawal or intoxication symptoms.
Use F18.90 when a patient is using inhalants without complications and when specific details about the inhalant type or severity are not documented.
